Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform

Saved in:
Bibliographic Details
Published in:PLOS ONE
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864030190822227970
collection WordPress RSS
FRELIP Feed Integration
container_title PLOS ONE
description
discipline_display Engineering & Technology
discipline_facet Engineering & Technology
format Online Article
RSS Article
genre Journal Article
id rss_article:8570
institution FRELIP
journal_source_facet PLOS ONE
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
Cybersecurity, Cryptography and Privacy
Computer Science & IT
Engineering & Technology
sub_discipline_display Computer Science & IT
sub_discipline_facet Computer Science & IT
subject_display Cybersecurity, Cryptography and Privacy
Computer Science & IT
Engineering & Technology
Cybersecurity, Cryptography and Privacy
Computer Science & IT
Engineering & Technology
subject_facet Cybersecurity, Cryptography and Privacy
Computer Science & IT
Engineering & Technology
title Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
title_auth Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
title_full Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
title_fullStr Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
title_full_unstemmed Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
title_short Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
title_sort durability of the bnt162b2 xbb:1.5-adapted vaccine against jn.1 hospitalisation in europe, october 2023 to august 2024: a test-negative case-control study using the id.drive platform
topic Cybersecurity, Cryptography and Privacy
Computer Science & IT
Engineering & Technology
url https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0342382